Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53 -Mutant Clonal Hematopoiesis

Archive ouverte

Kim, Rathana | Bergugnat, Hugo | Larcher, Lise | Duchmann, Matthieu | Passet, Marie | Gachet, Stéphanie | Cuccuini, Wendy | Lafage-Pochitaloff, Marina | Pastoret, Cédric | Grardel, Nathalie | Asnafi, Vahid | Schäfer, Beat | Delabesse, Eric | Itzykson, Raphaël | Adès, Lionel | Hicheri, Yosr | Chalandon, Yves | Graux, Carlos | Chevallier, Patrice | Hunault, Mathilde | Leguay, Thibaut | Huguet, Françoise | Lhéritier, Véronique | Dombret, Hervé | Soulier, Jean | Rousselot, Philippe | Boissel, Nicolas | Clappier, Emmanuelle

Edité par CCSD ; American Association for Cancer Research -

International audience. Unlabelled - Low hypodiploidy defines a rare subtype of B-cell acute lymphoblastic leukemia (B-ALL) with a dismal outcome. To investigate the genomic basis of low-hypodiploid ALL (LH-ALL) in adults, we analyzed copy-number aberrations, loss of heterozygosity, mutations, and cytogenetics data in a prospective cohort of Philadelphia (Ph)-negative B-ALL patients (n = 591, ages 18-84 years), allowing us to identify 80 LH-ALL cases (14%). Genomic analysis was critical for evidencing low hypodiploidy in many cases missed by cytogenetics. The proportion of LH-ALL within Ph-negative B-ALL dramatically increased with age, from 3% in the youngest patients (under 40 years old) to 32% in the oldest (over 55 years old). Somatic TP53 biallelic inactivation was the hallmark of adult LH-ALL, present in virtually all cases (98%). Strikingly, we detected TP53 mutations in posttreatment remission samples in 34% of patients. Single-cell proteogenomics of diagnosis and remission bone marrow samples evidenced a preleukemic, multilineage, TP53-mutant clone, reminiscent of age-related clonal hematopoiesis. Significance - We show that low-hypodiploid ALL is a frequent entity within B-ALL in older adults, relying on somatic TP53 biallelic alteration. Our study unveils a link between aging and low-hypodiploid ALL, with TP53-mutant clonal hematopoiesis representing a preleukemic reservoir that can give rise to aneuploidy and B-ALL. See related commentary by Saiki and Ogawa, p. 102. This article is highlighted in the In This Issue feature, p. 101.

Suggestions

Du même auteur

Genetic alterations and MRD refine risk assessment within KMT2A -rearranged B-cell precursor ALL in adult: a GRAALL study

Archive ouverte | Kim, Rathana | CCSD

International audience. KMT2A-rearranged (KMT2A-r) B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is widely recognized as a high-risk leukemia in both children and adults. However, there is a paucity of dat...

Frontline Consolidation with Nelarabine for Adults with High-Risk T-Cell Acute Lymphoblastic Leukemia. Results of the Graall-2014/T Atriall Phase 2 Study

Archive ouverte | Boissel, Nicolas | CCSD

International audience. Rationale: Acute lymphoblastic leukemia (ALL) with unfavorable biology and/or high minimal residual disease (MRD) levels are at high-risk of disease recurrence. Based on the results of the GR...

Concurrent CDX2 cis -deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL

Archive ouverte | Passet, Marie | CCSD

Oncogenic alterations underlying B-cell acute lymphoblastic leukemia (B-ALL) in adults remain incompletely elucidated. To uncover novel oncogenic drivers, we performed RNA sequencing and whole-genome analyses in a large cohort of ...

Chargement des enrichissements...